[Jump to Content]
This site's design is only visible in a graphical browser that supports web standards, but its content is accessible to any browser or Internet device.
Attention Deficit Disorder Resources
  
  envelopesend this page printerprinter friendly
[Content]

ADHD References

  • 1. Biederman Joseph, Faraone Stephen, et al: A prospective 4 year Follow–up Study of Attention–Deficit Hyperactivity disorder and Related Disorders. Arch Gen Psychiatry 1996;53:437–446
  • 2. Child and Adolescent Psychopharmacology Course, Harvard Medical School, March 13–15, 1998, Boston, Mass.
  • 3. Barrickman LL, Perry PJ, et al: Buproprion versus Methylphenidate in the Treatment of Attention Deficit Hyperactivity Disorder. J Am Acad Child Adolesc Psychiatry 1995, 34,5:649–657.
  • 4. Conners KC, Casat CD, et al: Bupropion Hydrochloride in Attention Deficit Disorder with Hyperactivity. J Am Acad Child Adolesc Psychiatry 1996,35;1314–1321.
  • 5. Cantwell DP: ADHD Through the Life Span: the role of Bupropion in treatment. J Clin Psychiatry 1998;59[suppl 4]:92–94.
  • 6. Gerring JP, Brady KD, et. al: Premorbid Prevalence of ADHD and Development of Secondary ADHD after closed head injury. 1998 J Am Acad Child Adolesc Psychiatry 37(6):647–654.
  • 7. Firestone P, Monteiro M, et. al: Short–term Side Effects of Stimulant Medication Are Increased in Preschool Children with ADHD; A Double–Blind Placebo–Controlled Study. Journal of Child and Adolescent Psychopharmacology 1998 8(1) 13–25.
  • 8. Pliszka SR: Comorbidity of Attention Deficit Hyperactivity disorder with Psyhciatric Disorder: an Overview. J Clin Psychiatry 1998;59[suppl 7]:50–58.
  • 9. Dunner DL, Zisook S, et al: A Prospective Safety Surveillance Study for Buproprion Sustained–Release in the Treatment of Depression. J Clin Psychiatry 1998;59:366–373.
  • 10. Gozal D: Sleep–disordered breathing and school performance in children. Pediatrics 1998 Sep; 102(3 Pt 1): 616–20.
  • 11. Gross–Tsur V Epilepsy and attention deficit hyperactivity disorder: is methylphenidate safe and effective? J Pediatr, 1997 Apr; 130(4): 670–4.
  • 12. Brasseux C, D'Angelo LJ, et al: The Changing Patttern of Substance Abuse in Urban Adolescents. Arch Pediatr Adolesc Med 1998;152:234–237.
  • 13. Lavigne JV, Arend R, et al: Psychiatric disorders With Onset in the Preschool Years: I. Stability of Diagnosis. 1998 J Am Acad Child Adolesc Psychiatry 37(12):1246–1254
  • 14. Lavigne JV, Arend R, et al: Psychiatric disorders With Onset in the Preschool Years:II Correlates and Predictors of Stable Case Status1998 J Am Acad Child Adolesc Psychiatry 37(12):1255–1261.
  • 15. Riggs PD, Leon SL, et al: An Open Trial of Buproprion ADHD in Adolescents With Substance Use Disorders and Conduct Disorder. 1998 J Am Acad Child Adolesc Psychiatry 37(12):1271–1278.
  • 16. Strassberger E ,Donnerstein D: Children, Adolescents, and the Media: Issues and Solutions (1999) Pediatrics 103:1:126–139.
  • 17. Stevens LJ :Omega–3 fatty acids in boys with behavior, learning, and health problems. Physiol Behav (1996)Apr–May; 59(4–5): 915–20.
  • 18. Murphy JM, Pagano ME, et al: the relationship of school breakfast to psychosocial and academic functioning. Arch Pediatr Adolesc Med 152:89, 1998.
  • 19. Kuperman S, Schlosser SS, et al: Relationship of Child Psychopathology to Parental Alcoholism and Antisocial Personality Disorder. J Am Acad Child Adolesc Psychiatry 1999, 38(6):686–692.
  • 20. Handen BL, Feldman HM et al: Efficacy of Methylphenidate Among Preschool Children With Developmental Disabilites and ADHD. . J Am Acad Child Adolesc Psychiatry 1999, 38(7):805–812.
  • 21. Gutgesell H, Atkins D, et al: AHA Scientific Statement: cardiovascular Monitoring of Children and Adolescents Receiving Psychotropic Drugs. J Am Acad Child Adolesc Psychiatry 1999, 38(8):1047–1050.
  • 22. Disney ER, Elkins IJ, et al: Effects of ADHD, Conduct Disorder, and Gender on Substance use and Abuse in Adolescence. Am J Psychiatry 1999, 156:1515–1521.
  • 23. Biederman J, Wilens T, et al: Psychoactive substance use disorders in adults with attention–deficit hyperactivity disorder (ADHD) Am J Psychiatry 1995,152: 1652–1658.
  • 24. Biederman J, et al: Pharmacotherapy of Attention–Deficit Hyperactivity Disorder Reduces Risk for Substance Use Disorder Pediatrics 1999;104 August (from internet section of the journal)
  • 25. Cook EH: The Early Development of Child Psychophamacogenetics. . J Am Acad Child Adolesc Psychiatry 1999, 38(12) 1478–1481.
  • 26. MTA cooperative group The Multimodal Treatment Study of Children With ADHD Arch Gen Psychiatry. 1999;56:1073–1086
  • 27. MTA cooperative group: Moderators and Mediators of Treatment Response for Children with ADHD Arch Gen Psychiatry 1999, 56:1088–1096
  • 28. Mota VL, Schachar RJ: Reformulating Attention–Deficit/Hyperactivity Disorder According to Signal Detection Theory. J Am Acad Child Adolesc Psychiatry2000, 39(9):1144–1151.\
  • 29. Greenhill LL, Swanson JM et. al: Impairment and Deportment Respinses to Different Methylphenidate Doses in Children with ADHD: the MTA Titration Trial. J Am Acad Child Adolesc Psychiatry2001, 40(2):180–187
  • 30. Vitiello B, Severe JB, et al: Methylphenidate Dosage for Children with ADHD Over Time Under Controlled conditions: Lessons from the MTA. J Am Acad Child Adolesc Psychiatry2001, 40(2):188–196.
  • 31. DuPaul GJ, McGoey KE, et. al. : Preschool Children With ADHD: Impairments in Behavioral, Social and School Functioning. . J Am Acad Child Adolesc Psychiatry2001, 40(5): 508–515
  • 32. Ghuman JK, Ginsburg GS, et. al.: Psychostimulants in Preschool Chidlren with ADHD: Clinical Evidence from a Developmetal Disorders Institution. . J Am Acad Child Adolesc Psychiatry2001, 40(5):516–524.
  • 33. Voigt RG, Llorente AM, et. al: A randomized, double–blind, placebo–controlled trial of docosahexaenoic acid supplementation in children with attention–deficit/hyperactivity disorder J Pediatr 2001;139:189–96.
  • 34. Brown TE: DSM–IV: ADHD and Executive Function Impairments. Advanced Studies in Medicine 2002;2 (25): 910–914.
  • 35. Hazel PL, Stuart JE: A Randomized Controlled Trial of Clonidine Added to Psychostimulant Medication for Hyperactive and Aggressive Children. J Am Acad Child Adolesc Psychiatry2001, 42(8):886–894.
  • 36. Swanson J, Gupta S et al: Development of a New Once–a–Day Formulation of Methylphenidate for the Treatment of Attention–deficit/Hyperactivity Disorder. Arch Gen Psychiatry, 2003;60:204–211.
  • 37. McCracken JT, Biederman J, et al: Analog Classroom Assessment of a Once–Daily Mixed Amphetamine Formulation, SL1381 (ADDERALL XR) in Children With ADHD. J Am Acad Child Adolesc Psychiatry 2003 Jun;42(6); 673–688.
  • 38. McGough JJ, Biederman J et al: Pharmacokinetics of SL1381 (ADDERALL XR), and Extended –Release Formulation of Adderall. J Am Acad Child Adolesc Psychiatry 2003 Jun;42(6); 673–688
  • 39. Rugino TA Modafinil in children with attention–deficit hyperactivity disorder. Pediatr Neurol – 01–AUG–2003; 29(2): 136–42
  • 40. Wilens T, Dodson W: A Clinical Perspective of ADHD into Adulthood. J clin Psychiatry 2004 65: 1301–1313






^top
We are a member driven non–profit organization. We depend on your support
through membership and donations to make our work possible.
is our text too small to read?